Literature DB >> 21189379

Durable complete remission induced by cetuximab monotherapy in a patient infected with HIV and diagnosed with recurrent squamous cell carcinoma of the head and neck.

Paul G Rubinstein1, Valerie Lindgren, Suman Setty, Mike Yao, Kristen B Pytynia, James A Radosevich, ShriHari S Kadkol, Lawrence E Feldman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21189379     DOI： 10.1200/JCO.2010.32.1927

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  2 in total

1.  Novel preclinical gastroenteropancreatic neuroendocrine neoplasia models demonstrate the feasibility of mutation-based targeted therapy.

Authors:  Fabrice Viol; Bence Sipos; Martina Fahl; Till S Clauditz; Tania Amin; Malte Kriegs; Maike Nieser; Jakob R Izbicki; Samuel Huber; Ansgar W Lohse; Jörg Schrader
Journal:  Cell Oncol (Dordr)       Date:  2022-10-21       Impact factor: 7.051

2.  Exceptional response to cetuximab monotherapy in a patient with metastatic oropharyngeal squamous cell carcinoma: a molecular insight.

Authors:  Prakash Peddi; Bhavna Paryani; Amol Takalkar; Paige Bundrick; John Ponugupati; Binu Nair; Hazem El-Osta
Journal:  Onco Targets Ther       Date:  2016-02-09       Impact factor: 4.147
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.